Teclistamab therapy for refractory type 1 cryoglobulinemia Teclistamab in type 1 cryoglobulinemia
Authors
- Vaishali Sanchorawala (ORCID: https://orcid.org/0000-0002-6307-2445)
- Joel Henderson (ORCID: https://orcid.org/0000-0002-9178-1708)
- Raphael Elie Szalat (ORCID: https://orcid.org/0000-0002-6198-3405)
- James W. Battaglini
Institutions
- Boston University (US)
- Boston Medical Center (US)
- Amyloidosis Foundation (US)
Publication Details
- Journal
- Haematologica
- Published
- 2025-03-20
- DOI
- https://doi.org/10.3324/haematol.2025.287313
- Citations
- 1
- Primary Topic
- Chronic Lymphocytic Leukemia Research
- Type
- article
- Field-Weighted Citation Impact
- 1.63